Page last updated: 2024-12-11

s-(1,2-dichlorovinyl)glutathione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6437359
CHEBI ID34957
MeSH IDM0123004

Synonyms (14)

Synonym
(e)-s-(1,2-dichlorovinyl)glutathione
glycine, n-(s-(1,2-dichloroethenyl)-n-l-gamma-glutamyl-l-cysteinyl)-, (e)-
(e)-n-(s-(1,2-dichloroethenyl)-n-l-gamma-glutamyl-l-cysteinyl)glycine
ccris 2074
s-(1,2-dichlorovinyl)glutathione
dcvg
(2s)-2-amino-5-[[(2r)-1-(carboxymethylamino)-3-[(e)-1,2-dichloroethenyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
s-(1,2-dichlorovinyl)-glutathione
96614-59-4
CHEBI:34957
2148-32-5
n5-((r)-1-((carboxymethyl)amino)-3-(((e)-1,2-dichlorovinyl)thio)-1-oxopropan-2-yl)-l-glutamine
Q27116336
DTXSID101034548

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" DCVC was consistently found to be more toxic than DCVG, but the inclusion of gamma-glutamyltransferase (0."( Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells.
Chen, JC; Jones, TW; Stevens, JL; Trifillis, AL, 1990
)
0.28
" S-(1,2-Dichlorovinyl)-L-glutathione is not toxic when the cells are pretreated with AT-125, an inhibitor of gamma-glutamyl transpeptidase."( The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells.
Hayden, P; Stevens, J; Taylor, G, 1986
)
0.27
" DCVG was toxic to HPT cells, but the onset of toxicity was delayed compared with the corresponding cysteine conjugate."( Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells.
Hawksworth, GM; Lock, EA; McGoldrick, TA; Rodilla, V, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" There was no evidence of morphological change in the kidneys and only small increases in biochemical markers of kidney damage in rats dosed with 2000 mg/kg trichloroethylene by gavage for 42 days."( The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene.
Dow, J; Ellis, MK; Foster, JR; Green, T; Odum, J, 1997
)
0.3
" Oral dosing with TCE was conducted in subacute (600 mg/kg/d; 5 d; 7 inbred mouse strains) and subchronic (100 or 400 mg/kg/d; 1, 2, or 4 wk; 2 inbred mouse strains) designs."( Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects.
Ball, LM; Bodnar, WM; Bradford, BU; Collins, LB; Gold, A; Kosyk, O; Rusyn, I; Shymonyak, S; Uehara, T; Yoo, HS, 2015
)
0.42
" Oral dosing with TCE was conducted in subacute (600 mg/kg/d; 5 d; 7 inbred mouse strains) and subchronic (100 or 400 mg/kg/d; 1, 2, or 4 wk; 2 inbred mouse strains) designs."( Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: kidney effects.
Ball, LM; Bodnar, WM; Bradford, BU; Collins, LB; Gold, A; Kosyk, O; Rusyn, I; Shymonyak, S; Uehara, T; Yoo, HS, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
peptideAmide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (27.27)18.7374
1990's7 (31.82)18.2507
2000's5 (22.73)29.6817
2010's3 (13.64)24.3611
2020's1 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.27 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.17%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]